HQ SPECLT PHARMA
GenericsHQ SPECLT PHARMA is a generic drug manufacturer focused on Infectious Disease, Dermatology, Gastroenterology.
HQ SPECLT PHARMA's Key Drugs
HQ SPECLT PHARMA's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
HQ SPECLT PHARMA's Recent FDA Approvals
New NDA/BLA approvals for HQ SPECLT PHARMA over the last two years — novel drugs only, excluding generics and label supplements.
HQ SPECLT PHARMA's Therapeutic Areas
HQ SPECLT PHARMA's approved drugs and pipeline span 3 therapeutic areas, led by Infectious Disease and Dermatology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
HQ SPECLT PHARMA's Top Competitors
HQ SPECLT PHARMA's closest competitors by therapeutic-area and drug-target overlap include APOTHECON, Pfizer, and PF PRISM CV. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
HQ SPECLT PHARMA Pipeline Snapshot
Active clinical trials for HQ SPECLT PHARMA across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Infectious Disease pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1992-07-14
- Latest
- 2026-01-19
- Applications
- 6